Literature DB >> 15327535

An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report.

S H Ibbotson1, D Bilsland, N H Cox, R S Dawe, B Diffey, C Edwards, P M Farr, J Ferguson, G Hart, J Hawk, J Lloyd, C Martin, H Moseley, K McKenna, L E Rhodes, D K Taylor.   

Abstract

Summary These guidelines for use of narrowband (TL-01) ultraviolet B have been prepared for dermatologists by the British Photodermatology Group on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment of patients with a variety of dermatoses and photodermatoses, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of background photobiology.

Entities:  

Mesh:

Year:  2004        PMID: 15327535     DOI: 10.1111/j.1365-2133.2004.06128.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  22 in total

1.  Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.

Authors:  Kevin Phan; Vignesh Ramachandran; Hiva Fassihi; Deshan F Sebaratnam
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

2.  Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.

Authors:  Youssef Elbayoumy Youssef; Heba Elsayed Abdelmoneim Eldegla; Rana Samir Mahmoud Elmekkawy; Mohammad Ali Gaballah
Journal:  Arch Dermatol Res       Date:  2022-03-23       Impact factor: 3.017

3.  Risk of Skin Cancer with Phototherapy in Moderate-to-Severe Psoriasis: An Updated Systematic Review.

Authors:  Akshitha Thatiparthi; Amylee Martin; Jeffrey Liu; Jashin J Wu
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 4.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

5.  Cost effectiveness of home ultraviolet B phototherapy for psoriasis: economic evaluation of a randomised controlled trial (PLUTO study).

Authors:  Mayke B G Koek; Vigfús Sigurdsson; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Erik Buskens
Journal:  BMJ       Date:  2010-04-20

6.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

7.  Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.

Authors:  Jonathan M Batchelor; Kim S Thomas; Perways Akram; Jaskiran Azad; Anthony Bewley; Joanne R Chalmers; Seau Tak Cheung; Lelia Duley; Viktoria Eleftheriadou; Robert Ellis; Adam Ferguson; Jonathan Mr Goulding; Rachel H Haines; Hamdi Hamad; John R Ingram; Bisola Laguda; Paul Leighton; Nick Levell; Areti Makrygeorgou; Garry D Meakin; Adam Millington; Malobi Ogboli; Amirtha Rajasekaran; Jane C Ravenscroft; Andrew Rogers; Tracey H Sach; Miriam Santer; Julia Stainforth; Wei Tan; Shyamal Wahie; Jennifer White; Maxine E Whitton; Hywel C Williams; Andrew Wright; Alan A Montgomery
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

8.  The effect of narrowband ultraviolet B phototherapy on serum folate level.

Authors:  Azar Shirzadian Kebria; Meghdad Hosseini; Sorayya Khafri
Journal:  Caspian J Intern Med       Date:  2021-03

9.  Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study).

Authors:  Mayke B G Koek; Erik Buskens; Huib van Weelden; Paul H A Steegmans; Carla A F M Bruijnzeel-Koomen; Vigfús Sigurdsson
Journal:  BMJ       Date:  2009-05-07

10.  Adverse Events Leading to Discontinuation of Phototherapy: An Observational Study.

Authors:  Isabel Belinchón; María J Sánchez-Pujol; Alejandro Docampo; Laura Cuesta; Luca Schneller-Pavelescu; Jose M Ramos-Rincón
Journal:  Acta Derm Venereol       Date:  2020-03-18       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.